U

University Hospital Würzburg | Internal Medicine II, Haematology and Oncology Department

Research site

(Unclaimed)

Location

Medical Klinik II, Zentrum International Medicine Building A4, +1, 426, Würzburg, Bavaria, Germany

Site insights

Top conditions

Top treatments

Cabozantinib

VItamin C

Carboplatin

Prednisone

APL-2

Teclistamab

Pemetrexed

Trametinib

Chemotherapy

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 37 total trials

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (DTU-STEMI)

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior t...

Active, not recruiting

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Device: Impella CP® placement prior to reperfusion with Primary PCI

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

This is an exploratory, signal finding, randomized, placebo-controlled, blinded, multi-center Phase 2b trial of the anti GDF-15 antibody Visugromab (...

Enrolling

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Adult Solid Tumor

Biological: Visugromab

Drug: Pemetrexed 500 mg/m^2